Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 83 EEO3 | DOI: 10.1530/endoabs.83.EEO3

EYES2022 ESE Young Endocrinologists and Scientists (EYES) 2022 Environmental Endocrinology (4 abstracts)

Commercially available multivitamin supplements during pregnancy are ineffective for optimal selenium supply for mothers and newborns

Filipowicz D 1 , Szczepanek-Parulska E 1 , Schomburg L 2 & Ruchała M 1

1 Poznan University of Medical Sciences, Department of Endocrinology, Metabolism and Internal Medicine; 2 Charité - Universitätsmedizin Berlin, Institute for Experimental Endocrinology

Background: Selenium (Se) sufficiency is beneficial for thyroid metabolism and pregnancy course due to its antioxidant and anti-inflammatory properties. As a part of selenoenzymes, it ameliorates autoimmune thyroid disease (AITD) progression in mothers and provides proper neurogenesis in fetuses. Despite lacking or conflicting recommendations for its supplementation in pregnancy, Se is used in a clinical setting, as a common constituent of multivitamin pregnancy diet supplements.

Objectives: The aim of the study was to evaluate Se supply and real-life supplementation effectiveness in pregnancy, based on Se biomarkers assessment in mothers and their newborns.

Methods: 115 mother-child pairs were recruited at term delivery from obstetric department in one Polish centre. By the medical interview Se supplementation during pregnancy was assessed. The blood was collected before childbirth in mothers and during the third phase of delivery from the newborns’ cord blood. Se status was assessed by measuring serum Se and selenoprotein P (SELENOP) concentrations and glutathione peroxidase 3 (GPX3) activity.

Results: Se intake was declared by 30% of women, using multi-micronutrient supplements, with a mean Se dosage (± SD) of 42 ± 14 µg/day. The whole group was deficient in Se in 89% (Se <70 µg/l) and SELENOP in 77%. Median serum Se (54 vs. 58 µg/l), SELENOP (2.2 vs. 2.3 mg/l), or GPX3 (199 vs. 208.5 U/l) concentrations were slightly but not significantly higher in the supplemented than non-supplemented group. However, in the subgroups of low (< 55 µg/day) and moderate (≥ 55 µg/day) daily Se dosage, median SELENOP was significantly higher in the latter group (1.84 vs. 3.17 mg/l, p = 0.006). Additionally, positive correlations of Se (z = 8.07, P < 0.001), SELENOP (z = 5.15, P < 0.001) and GPX3 (z = 7.41, P < 0.001) within mother-newborn pairs were observed.

Conclusions: Se supplementation from pregnancy multivitamin formulas was ineffective in the presented cohort. The mothers’ Se supply reflects Se bioavailability for newborns. Considering diversity in geographical Se stores, differences in diet and individual Se level, no common guidelines can be applied worldwide, thus, there is a need of local Se status verification and adjusted recommendations.

Volume 83

ESE Young Endocrinologists and Scientists (EYES) 2022

Zagreb, Croatia
02 Sep 2022 - 04 Sep 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.